A study for a 61 year old woman who takes Meloxicam, Zoloft, Levothyroxine Thyroid, Estradiol, Progesterone (an AI-powered real world drug study)

Summary:

37 females aged 61 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 61 year old female patient who has Underactive Thyroid, Depression, Joint Pain, Menopause. The study is created by eHealthMe based on reports from sources including the FDA.


On Jan, 23, 2026

37 females aged 61 (±5) who take Meloxicam, Zoloft, Levothyroxine Thyroid, Estradiol, Progesterone and have adverse effects are studied.


Number of reports submitted per year:

Meloxicam, Zoloft, Levothyroxine Thyroid, Estradiol, Progesterone for a 61-year old woman.

Information of the patient in this study:

  • Age: 61
  • Gender: female

What are the drugs?

What are the conditions?

What are the adverse effects?


Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

  • Irritability:
    - among females aged 61 (±5) who take the same drugs: 0% (0 of 37)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 125)
  • Joint Stiffness:
    - among females aged 61 (±5) who take the same drugs: 0% (0 of 37)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 125)
  • Dry Mouth:
    - among females aged 61 (±5) who take the same drugs: 0% (0 of 37)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 125)
  • Postnasal Drip:
    - among females aged 61 (±5) who take the same drugs: 0% (0 of 37)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 125)
  • Bad Breath:
    - among females aged 61 (±5) who take the same drugs: 0% (0 of 37)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 125)
  • Exhaustion (tiredness):
    - among females aged 61 (±5) who take the same drugs: 0% (0 of 37)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 125)

By each condition:

  • people who have Bad Breath with Joint Pain:
    - among females aged 61 (±5) who have Joint Pain: 0% (0 of 7,484)
    - among people who have Joint Pain, regardless of gender or age: 0.01% (7 of 59,499)
  • people who have Bad Breath with Underactive Thyroid:
    - among females aged 61 (±5) who have Underactive Thyroid: 0.07% (14 of 18,729)
    - among people who have Underactive Thyroid, regardless of gender or age: 0.03% (35 of 114,168)
  • people who have Bad Breath with Depression:
    - among females aged 61 (±5) who have Depression: 0.02% (9 of 38,735)
    - among people who have Depression, regardless of gender or age: 0.02% (78 of 344,182)
  • people who have Bad Breath with Menopause:
    - among females aged 61 (±5) who have Menopause: 0.04% (1 of 2,666)
    - among people who have Menopause, regardless of gender or age: 0.03% (3 of 9,747)
  • people who have Dry Mouth with Menopause:
    - among females aged 61 (±5) who have Menopause: 0.79% (21 of 2,666)
    - among people who have Menopause, regardless of gender or age: 0.84% (82 of 9,747)
  • people who have Dry Mouth with Underactive Thyroid:
    - among females aged 61 (±5) who have Underactive Thyroid: 1.09% (205 of 18,729)
    - among people who have Underactive Thyroid, regardless of gender or age: 1.04% (1,188 of 114,168)
  • people who have Dry Mouth with Depression:
    - among females aged 61 (±5) who have Depression: 1.61% (623 of 38,735)
    - among people who have Depression, regardless of gender or age: 1.14% (3,940 of 344,182)
  • people who have Dry Mouth with Joint Pain:
    - among females aged 61 (±5) who have Joint Pain: 1.43% (107 of 7,484)
    - among people who have Joint Pain, regardless of gender or age: 0.83% (495 of 59,499)
  • people who have Exhaustion with Joint Pain:
    - among females aged 61 (±5) who have Joint Pain: 8.52% (638 of 7,484)
    - among people who have Joint Pain, regardless of gender or age: 5.73% (3,410 of 59,499)
  • people who have Exhaustion with Menopause:
    - among females aged 61 (±5) who have Menopause: 6.98% (186 of 2,666)
    - among people who have Menopause, regardless of gender or age: 7.09% (691 of 9,747)
  • people who have Exhaustion with Depression:
    - among females aged 61 (±5) who have Depression: 7.43% (2,877 of 38,735)
    - among people who have Depression, regardless of gender or age: 6.44% (22,166 of 344,182)
  • people who have Exhaustion with Underactive Thyroid:
    - among females aged 61 (±5) who have Underactive Thyroid: 10.5% (1,967 of 18,729)
    - among people who have Underactive Thyroid, regardless of gender or age: 9.26% (10,574 of 114,168)
  • people who have Irritability with Menopause:
    - among females aged 61 (±5) who have Menopause: 1.31% (35 of 2,666)
    - among people who have Menopause, regardless of gender or age: 1.36% (133 of 9,747)
  • people who have Irritability with Depression:
    - among females aged 61 (±5) who have Depression: 1.64% (636 of 38,735)
    - among people who have Depression, regardless of gender or age: 1.89% (6,496 of 344,182)
  • people who have Irritability with Joint Pain:
    - among females aged 61 (±5) who have Joint Pain: 0.39% (29 of 7,484)
    - among people who have Joint Pain, regardless of gender or age: 0.36% (213 of 59,499)
  • people who have Irritability with Underactive Thyroid:
    - among females aged 61 (±5) who have Underactive Thyroid: 1.12% (210 of 18,729)
    - among people who have Underactive Thyroid, regardless of gender or age: 0.9% (1,033 of 114,168)
  • people who have Joint Stiffness with Depression:
    - among females aged 61 (±5) who have Depression: 0.23% (89 of 38,735)
    - among people who have Depression, regardless of gender or age: 0.17% (598 of 344,182)
  • people who have Joint Stiffness with Menopause:
    - among females aged 61 (±5) who have Menopause: 0.19% (5 of 2,666)
    - among people who have Menopause, regardless of gender or age: 0.21% (20 of 9,747)
  • people who have Joint Stiffness with Joint Pain:
    - among females aged 61 (±5) who have Joint Pain: 2.58% (193 of 7,484)
    - among people who have Joint Pain, regardless of gender or age: 0.77% (459 of 59,499)
  • people who have Joint Stiffness with Underactive Thyroid:
    - among females aged 61 (±5) who have Underactive Thyroid: 0.45% (84 of 18,729)
    - among people who have Underactive Thyroid, regardless of gender or age: 0.29% (326 of 114,168)
  • people who have Postnasal Drip with Menopause:
    - among females aged 61 (±5) who have Menopause: 0% (0 of 2,666)
    - among people who have Menopause, regardless of gender or age: 0% (0 of 9,747)
  • people who have Postnasal Drip with Joint Pain:
    - among females aged 61 (±5) who have Joint Pain: 0% (0 of 7,484)
    - among people who have Joint Pain, regardless of gender or age: 0.02% (9 of 59,499)
  • people who have Postnasal Drip with Underactive Thyroid:
    - among females aged 61 (±5) who have Underactive Thyroid: 0% (0 of 18,729)
    - among people who have Underactive Thyroid, regardless of gender or age: 0.01% (8 of 114,168)
  • people who have Postnasal Drip with Depression:
    - among females aged 61 (±5) who have Depression: 0.01% (3 of 38,735)
    - among people who have Depression, regardless of gender or age: 0.02% (66 of 344,182)

By each drug (FDA data only):

  • people who take Zoloft and have Bad Breath:
    - among females aged 61 (±5) who take Zoloft and have side effects: 0.02% (3 of 12,600)
    - among people who take Zoloft and have side effects, regardless of gender or age: 0.05% (65 of 128,192)
  • people who take Progesterone and have Bad Breath:
    - among females aged 61 (±5) who take Progesterone and have side effects: 0.05% (2 of 3,759)
    - among people who take Progesterone and have side effects, regardless of gender or age: 0.03% (7 of 20,010)
  • people who take Levothyroxine Thyroid and have Bad Breath:
    - among females aged 61 (±5) who take Levothyroxine Thyroid and have side effects: 0% (0 of 0)
    - among people who take Levothyroxine Thyroid and have side effects, regardless of gender or age: 0% (0 of 0)
  • people who take Meloxicam and have Bad Breath:
    - among females aged 61 (±5) who take Meloxicam and have side effects: 0% (0 of 10,063)
    - among people who take Meloxicam and have side effects, regardless of gender or age: 0.01% (9 of 64,773)
  • people who take Estradiol and have Bad Breath:
    - among females aged 61 (±5) who take Estradiol and have side effects: 0% (0 of 3,169)
    - among people who take Estradiol and have side effects, regardless of gender or age: 0.01% (1 of 17,355)
  • people who take Estradiol and have Dry Mouth:
    - among females aged 61 (±5) who take Estradiol and have side effects: 1.39% (44 of 3,169)
    - among people who take Estradiol and have side effects, regardless of gender or age: 0.99% (172 of 17,355)
  • people who take Progesterone and have Dry Mouth:
    - among females aged 61 (±5) who take Progesterone and have side effects: 1.6% (60 of 3,759)
    - among people who take Progesterone and have side effects, regardless of gender or age: 0.92% (185 of 20,010)
  • people who take Zoloft and have Dry Mouth:
    - among females aged 61 (±5) who take Zoloft and have side effects: 1.17% (147 of 12,600)
    - among people who take Zoloft and have side effects, regardless of gender or age: 1% (1,281 of 128,192)
  • people who take Levothyroxine Thyroid and have Dry Mouth:
    - among females aged 61 (±5) who take Levothyroxine Thyroid and have side effects: 0% (0 of 0)
    - among people who take Levothyroxine Thyroid and have side effects, regardless of gender or age: 0% (0 of 0)
  • people who take Meloxicam and have Dry Mouth:
    - among females aged 61 (±5) who take Meloxicam and have side effects: 1.19% (120 of 10,063)
    - among people who take Meloxicam and have side effects, regardless of gender or age: 1.67% (1,084 of 64,773)
  • people who take Estradiol and have Exhaustion:
    - among females aged 61 (±5) who take Estradiol and have side effects: 9.18% (291 of 3,169)
    - among people who take Estradiol and have side effects, regardless of gender or age: 7.34% (1,273 of 17,355)
  • people who take Meloxicam and have Exhaustion:
    - among females aged 61 (±5) who take Meloxicam and have side effects: 8.06% (811 of 10,063)
    - among people who take Meloxicam and have side effects, regardless of gender or age: 9.22% (5,974 of 64,773)
  • people who take Zoloft and have Exhaustion:
    - among females aged 61 (±5) who take Zoloft and have side effects: 8.74% (1,101 of 12,600)
    - among people who take Zoloft and have side effects, regardless of gender or age: 7.13% (9,136 of 128,192)
  • people who take Levothyroxine Thyroid and have Exhaustion:
    - among females aged 61 (±5) who take Levothyroxine Thyroid and have side effects: 0% (0 of 0)
    - among people who take Levothyroxine Thyroid and have side effects, regardless of gender or age: 0% (0 of 0)
  • people who take Progesterone and have Exhaustion:
    - among females aged 61 (±5) who take Progesterone and have side effects: 17% (639 of 3,759)
    - among people who take Progesterone and have side effects, regardless of gender or age: 9.74% (1,948 of 20,010)
  • people who take Estradiol and have Irritability:
    - among females aged 61 (±5) who take Estradiol and have side effects: 0.5% (16 of 3,169)
    - among people who take Estradiol and have side effects, regardless of gender or age: 0.57% (99 of 17,355)
  • people who take Progesterone and have Irritability:
    - among females aged 61 (±5) who take Progesterone and have side effects: 0.59% (22 of 3,759)
    - among people who take Progesterone and have side effects, regardless of gender or age: 0.62% (124 of 20,010)
  • people who take Levothyroxine Thyroid and have Irritability:
    - among females aged 61 (±5) who take Levothyroxine Thyroid and have side effects: 0% (0 of 0)
    - among people who take Levothyroxine Thyroid and have side effects, regardless of gender or age: 0% (0 of 0)
  • people who take Meloxicam and have Irritability:
    - among females aged 61 (±5) who take Meloxicam and have side effects: 0.39% (39 of 10,063)
    - among people who take Meloxicam and have side effects, regardless of gender or age: 0.36% (234 of 64,773)
  • people who take Zoloft and have Irritability:
    - among females aged 61 (±5) who take Zoloft and have side effects: 0.77% (97 of 12,600)
    - among people who take Zoloft and have side effects, regardless of gender or age: 1.18% (1,519 of 128,192)
  • people who take Levothyroxine Thyroid and have Joint Stiffness:
    - among females aged 61 (±5) who take Levothyroxine Thyroid and have side effects: 0% (0 of 0)
    - among people who take Levothyroxine Thyroid and have side effects, regardless of gender or age: 0% (0 of 0)
  • people who take Zoloft and have Joint Stiffness:
    - among females aged 61 (±5) who take Zoloft and have side effects: 0.37% (46 of 12,600)
    - among people who take Zoloft and have side effects, regardless of gender or age: 0.25% (319 of 128,192)
  • people who take Meloxicam and have Joint Stiffness:
    - among females aged 61 (±5) who take Meloxicam and have side effects: 0.72% (72 of 10,063)
    - among people who take Meloxicam and have side effects, regardless of gender or age: 0.64% (416 of 64,773)
  • people who take Estradiol and have Joint Stiffness:
    - among females aged 61 (±5) who take Estradiol and have side effects: 0.16% (5 of 3,169)
    - among people who take Estradiol and have side effects, regardless of gender or age: 0.18% (32 of 17,355)
  • people who take Progesterone and have Joint Stiffness:
    - among females aged 61 (±5) who take Progesterone and have side effects: 0.35% (13 of 3,759)
    - among people who take Progesterone and have side effects, regardless of gender or age: 0.35% (71 of 20,010)
  • people who take Progesterone and have Postnasal Drip:
    - among females aged 61 (±5) who take Progesterone and have side effects: 0% (0 of 3,759)
    - among people who take Progesterone and have side effects, regardless of gender or age: 0% (1 of 20,010)
  • people who take Estradiol and have Postnasal Drip:
    - among females aged 61 (±5) who take Estradiol and have side effects: 0% (0 of 3,169)
    - among people who take Estradiol and have side effects, regardless of gender or age: 0.01% (2 of 17,355)
  • people who take Meloxicam and have Postnasal Drip:
    - among females aged 61 (±5) who take Meloxicam and have side effects: 0% (0 of 10,063)
    - among people who take Meloxicam and have side effects, regardless of gender or age: 0% (1 of 64,773)
  • people who take Zoloft and have Postnasal Drip:
    - among females aged 61 (±5) who take Zoloft and have side effects: 0.04% (5 of 12,600)
    - among people who take Zoloft and have side effects, regardless of gender or age: 0.05% (66 of 128,192)
  • people who take Levothyroxine Thyroid and have Postnasal Drip:
    - among females aged 61 (±5) who take Levothyroxine Thyroid and have side effects: 0% (0 of 0)
    - among people who take Levothyroxine Thyroid and have side effects, regardless of gender or age: 0% (0 of 0)

Common drug interactions *:

  1. Scoliosis (a medical condition in which a person's spine is curved from side to side): 7 people, 18.92%
  2. Blood Calcium Decreased : 6 people, 16.22%
  3. High Blood Pressure : 6 people, 16.22%
  4. Fatigue (feeling of tiredness): 6 people, 16.22%
  5. Dyspnea (difficult or laboured breathing): 5 people, 13.51%
  6. Nasopharyngitis (inflammation of the nasopharynx): 4 people, 10.81%
  7. Multiple Allergies (allergy to multiple agents): 4 people, 10.81%
  8. Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 4 people, 10.81%
  9. Bleeding Into The Skin : 4 people, 10.81%
  10. Asthma : 4 people, 10.81%
  11. Breast Cancer : 4 people, 10.81%
  12. Sinusitis (inflammation of sinus): 4 people, 10.81%
  13. Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 4 people, 10.81%
  14. Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 4 people, 10.81%
  15. Upper Respiratory Tract Infection : 4 people, 10.81%
  16. Breast Pain : 4 people, 10.81%
  17. Insomnia (sleeplessness): 3 people, 8.11%
  18. Injury : 3 people, 8.11%
  19. Intervertebral Disc Displacement : 3 people, 8.11%
  20. Breast Cancer In Situ : 3 people, 8.11%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 24.32%
  2. Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 6 people, 16.22%
  3. Injection Site Reaction : 6 people, 16.22%
  4. Arrhythmias (irregular heartbeat): 6 people, 16.22%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 16.22%
  6. Head Injury : 6 people, 16.22%
  7. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 6 people, 16.22%
  8. Vulvovaginal Dryness : 6 people, 16.22%
  9. Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 16.22%
  10. Swallowing Difficulty : 6 people, 16.22%
  11. Primary Immunodeficiency Syndrome : 4 people, 10.81%
  12. Immunodeficiency Common Variable : 3 people, 8.11%
  13. Immunodeficiency : 2 people, 5.41%
  14. Asthma : 2 people, 5.41%
  15. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 5.41%
  16. Fungal Infection : 1 person, 2.70%
  17. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.70%
  18. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 2.70%
  19. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 2.70%
  20. Menopausal Symptoms : 1 person, 2.70%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Vitamin D3 (10 people, 27.03%)
  2. Lyrica (9 people, 24.32%)
  3. Xyrem (9 people, 24.32%)
  4. Xanax (9 people, 24.32%)
  5. Hydrocodone Bitartrate And Acetaminophen (7 people, 18.92%)
  6. Viibryd (7 people, 18.92%)
  7. Humira (7 people, 18.92%)
  8. Triamcinolone (7 people, 18.92%)
  9. Valtrex (7 people, 18.92%)
  10. Epipen (7 people, 18.92%)
  11. Evista (7 people, 18.92%)
  12. Percocet (7 people, 18.92%)
  13. Nuvigil (7 people, 18.92%)
  14. Adderall (7 people, 18.92%)
  15. Flecainide Acetate (6 people, 16.22%)
  16. Monazol (6 people, 16.22%)
  17. Xyzal (6 people, 16.22%)
  18. Rabeprazole Sodium (6 people, 16.22%)
  19. Baclofen (6 people, 16.22%)
  20. Gaviscon (6 people, 16.22%)

Drug effectiveness *:

Meloxicam:

n/a

Zoloft:

n/a

Levothyroxine Thyroid:

n/a

Estradiol:

n/a

Progesterone:

n/a

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug side effects:

Drug interactions:

Symptoms:

Drugs that are associated with:

Conditions that are associated with:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent personalized studies on eHealthMe: